XNAS
SKYA
Market cap112mUSD
Oct 16, Last price
2.65USD
1D
-3.28%
1Q
128.45%
IPO
-99.98%
Name
Sharps Technology Inc
Chart & performance
P/E
—
P/S
549.45
EPS
—
Div yield, %
—
Shs. 5Y
611.38%
Rev. 5Y
%
Revenues
204k
Net income
-283m
L+2,938.90%
CFO
-17m
L+141.27%
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Sharps Technology, Inc., a medical device and pharmaceutical packaging company, provides smart-safety syringe products to the healthcare industry. Its product lines focus on providing waste capabilities that incorporate syringe technologies. The company, through a digital asset treasury strategy, focuses on accumulating Solana (SOL), the native digital asset of the Solana blockchain. The company was incorporated in 2017 and is based in Melville, New York.
Key people
Paul Danner
Executive Chairman of the Board, Principal Executive Officer · since 2025
Soren Christiansen
Chairman of the Board · since 2023
Andrew Crescenzo
Chief Financial Officer · since 2019
Yuwen Zhang
Chief Investment Officer, Director · since 2025
Jason Monroe
Independent Director · since 2022
Timothy Ruemler
Independent Director · since 2021
Annemarie Tierney
Independent Director · since 2025
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | |
| Income | |||||||
Revenues | |||||||
Cost of revenue | |||||||
Unusual Expense (Income) | |||||||
NOPBT | |||||||
NOPBT Margin | |||||||
Operating Taxes | |||||||
Tax Rate | |||||||
NOPAT | |||||||
Net income | |||||||
Dividends | |||||||
Dividend yield | |||||||
Proceeds from repurchase of equity | |||||||
BB yield | |||||||
| Debt | |||||||
Debt current | |||||||
Long-term debt | |||||||
Deferred revenue | |||||||
Other long-term liabilities | |||||||
Net debt | |||||||
| Cash flow | |||||||
Cash from operating activities | |||||||
CAPEX | |||||||
Cash from investing activities | |||||||
Cash from financing activities | |||||||
FCF | |||||||
| Balance | |||||||
Cash | |||||||
Long term investments | |||||||
Excess cash | |||||||
Stockholders' equity | |||||||
Invested Capital | |||||||
ROIC | |||||||
ROCE | |||||||
| EV | |||||||
Common stock shares outstanding | |||||||
Price | |||||||
Market cap | |||||||
EV | |||||||
EBITDA | |||||||
EV/EBITDA | |||||||
Interest | |||||||
Interest/NOPBT | |||||||